Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-24 @ 6:31 PM
NCT ID:
NCT05812157
Eligibility Criteria:
Inclusion criteria:
* Patients with spondyloarthritis meeting the ASAS criteria
* Patient considered by the treating rheumatologist for anti-IL-17 biomedication
* Patients aged between 18 and 90 years of age
* Patients who are affiliated to a French social security system or beneficiaries of such a system
* Patients with no desire to become pregnant during the study period (Effective contraception for women of childbearing age during the study period (surgical sterilization, hormonal contraceptives, barrier method, intrauterine device))
Exclusion Criteria:
* Lack of written informed consent after a time of reflection
* Patients participating in other therapeutic research or having participated in research for which the exclusion period has not ended
* Patient under court protection, guardianship or curatorship.
* Patient unable to give consent.
* Pregnant or breastfeeding woman
* Patients with digestive disorders for which a chronic inflammatory bowel disease has not been excluded
* Patients with fructose intolerance or glucose or galactose malabsorption
* Patients with known intolerance to inulin or maltodextrin
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT05812157
Study Brief:
Protocol Section:
NCT05812157